From peptide to non-peptide: The design of LHRH antagonist mimetics

Fortuna Haviv, Wesley Dwight, Bradley Crawford, Rolf Swenson, Milan Bruncko, Michele Kaminski, Kaneyoshi Kato, Yoshihiro Sugiura, Lisa Frey, Gilbert Diaz, Gary Bammert, Eugene N. Bush, Leslie Besecke, Kurt Mohning, Jason Segreti, Mary Spangler, Craig Wegner, and Jonathan Greer Pharmaceutical Products Division, Abbott Laboratories, Abbott Park, IL 60064-3500, U.S.A.; Pharmaceutical Development Division, Takeda Chemical Industries, Osaka Japan; and TAP Pharmaceutical Inc., Abbott Park, IL 60064-3500, U.S.A.